Skip to main content
2025 CRT Conference Main banner

CRT 2025

Technology and Innovation

Renal Denervation and Hypertension Therapies

Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation

Sunday, March 9, 2025
11:56 AM - 12:15 PM ET

    Panel Moderator(s)

  • Herbert D. Aronow, MD, MPH

    Medical Director, Heart & Vascular Services
    Henry Ford Health
    Detroit, Michigan, United States

    No relationships to disclose

  • Justin E. Davies, MD, PhD

    Cardiologist
    Imperial College London
    London, England, United Kingdom

    Disclosure(s): No financial relationships to disclose

  • Timir Paul, MD, PhD, FACC, FSCAI

    Professor of Medicine; Program Director, Cardiovascular Disease Fellowship
    University of Tennessee Health Science Center- Nashville, Ascension St. Thomas Hospital
    Brentwood, Tennessee, United States

    No relationships to disclose

    • Panel Discussant(s)

  • Michael J. Bloch, MD

    Medical Director, Vascular Care
    Renown Institute for Heart and Vascular Health
    reno, Nevada, United States

    No relationships to disclose

  • Chandan M. Devireddy, MD

    Professor
    Emory University
    Emory University
    Atlanta, Georgia, United States

    Disclosure(s): Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consultant (Ongoing)

  • Dmitriy N. Feldman, FACC, FSCAI, FSVM

    Professor of Medicine
    Weill Cornell Medical College, New York Presbyterian Hospital
    New York, New York, United States

    No relationships to disclose

  • JF

    Jason Fontana, PhD

    Vice President Marketing and Strategy
    Medtronic, California, United States

    No relationships to disclose

  • James Stephen Jenkins, MD

    Section Head, Interventional Cardiology Director, Interventional Cardiology Research
    Ochsner Medical Center
    New Orleans, Louisiana, United States

    No relationships to disclose

  • Helen Reeve-Stoffer, PhD

    Chief Clinical Officer
    Recor Medical Inc
    Palo Alto, , California, United States

    Disclosure(s): Recor Medical: Employee (Ongoing)

  • Jie Wang, MD, PhD

    Professor
    Jiangsu Province Hospital
    Nanjing, Jiangsu, China (People's Republic)

    No relationships to disclose

  • Judith Veis, MD

    Section Director, Nephrology
    Medstar Washington Hospital Center
    Washington, District of Columbia, United States

    No relationships to disclose

  • James P. Zidar, MD, FSCAI

    Clinical Professor of Medicine
    University of North Carolina/Rex Healthcare
    Raleigh, North Carolina, United States

    Disclosure information not submitted.

Disclosure(s):
Herbert D. Aronow, MD, MPH: Amplitude Vascular Systems: Consultant (Ongoing); Medtronic: Consultant (Ongoing); Novartis Pharmaceuticals: Consultant (Terminated); Rapid AI: Consultant (Ongoing)
Justin E. Davies, MD, PhD: No financial relationships to disclose
Timir Paul, MD, PhD, FACC, FSCAI: No financial relationships to disclose
Michael J. Bloch, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); baralogics: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); janssen: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoniVie: Grant/Research Support (Ongoing)
Chandan M. Devireddy, MD: Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consultant (Ongoing)
Dmitriy N. Feldman, FACC, FSCAI, FSVM: No financial relationships to disclose
James Stephen Jenkins, MD: Abbott Labs: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Helen Reeve-Stoffer, PhD: Recor Medical: Employee (Ongoing)
Jie Wang, MD, PhD: SyMap Medical Ltd, Suzhou, China: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)
Judith Veis, MD: No financial relationships to disclose
James P. Zidar, MD, FSCAI: CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing)